CPT code 81209: BLM test, 2281del6ins7 variant2026 Medicare lab fee · Clinical Laboratory Fee Schedule
Targeted BLM gene analysis for the 2281del6ins7 variant associated with Bloom syndrome is reported when that specific molecular target is tested.
Medicare pays $39.31 for 81209 under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.
Medicare lab fee · CLFS 2026 Q4
National CLFS amount
$39.31
In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.
- Geographic adjustment
- None
- Office vs facility
- Same
- Since 2020
- Unchanged
- CMS updates
- Quarterly
Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.
On this page 7 sections
What 81209 covers
CPT 81209 represents a targeted molecular analysis of the BLM gene for the 2281del6ins7 variant associated with Bloom syndrome. The code identifies this specific variant-level test rather than comprehensive sequencing of BLM or testing of another gene. Laboratory reporting under this code should correspond to analysis of that target; a broader BLM assay is not represented by 81209 solely because it includes the gene. This is a clinical laboratory service.
Medicare pays 81209 only through the CLFS. The 2026 national CLFS amount is $39.31 and has remained unchanged from 2020 through 2026. The same amount applies nationally, without locality adjustment or a difference between office and facility settings. The test is excluded from physician fee schedule payment and is paid only from the CLFS.
This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.
How Medicare pays 81209
Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.
One national amount
CMS sets a single Clinical Laboratory Fee Schedule amount for 81209. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.
No office or facility rate
Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.
Updated every quarter
CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.
Excluded from the physician fee schedule
The physician fee schedule lists 81209 with status X (excluded by statute), so the test itself is paid only from the CLFS.
81209 on the lab fee schedule since 2020
81209 · CLFS 2026 Q4 (current)
$39.31
Unchanged since Jan 1, 2020
27 quarterly CLFS releases on file, first CLFS 2020 Q1. A code missing from a quarter wasn’t on that release.
81209 compared with similar tests
- 81212BRCA testingThree specified variants$440.00
- 81212 covers selected BRCA1 and BRCA2 variants; 81209 targets the BLM 2281del6ins7 variant associated with Bloom syndrome.
- 81206BCR-ABL1 testMajor breakpoint$163.96
- 81206 targets a major-breakpoint BCR/ABL1 analysis, while 81209 targets a specific BLM variant.
- 81207BCR::ABL1 testMinor breakpoint$144.84
- 81207 targets a minor-breakpoint BCR/ABL1 analysis, while 81209 targets a specific BLM variant.
81209 billing questions
Which BLM variant does 81209 analyze?
It targets the BLM 2281del6ins7 variant associated with Bloom syndrome.
Does 81209 cover comprehensive BLM sequencing?
No. It represents analysis of the specified BLM variant, not comprehensive sequencing of the gene.
How does 81209 differ from 81206?
81206 targets a major-breakpoint BCR/ABL1 analysis; 81209 targets the specified BLM variant.
How does Medicare pay for 81209?
Medicare pays it through the CLFS at one national amount, with no locality or office-versus-facility difference.
Is 81209 paid under the physician fee schedule?
No. The test is excluded from the physician fee schedule and is paid only through the CLFS.
Where this amount comes from
FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.
CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027
Show the CMS file line behind this amount
Fee sheets · Coming soon
Put 81209 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist